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1. Introduction
  The process of wound healing occurs in three stages, 
inflammation, proliferation and remodeling. The basic 
principles of wound healing like minimizing tissue damage, 
debriding non viable tissue, maximizing tissue perfusion 
and oxygenation, proper nutrition and moist wound healing 
environment have been recognized for many years[1]. Great 
number of drugs are being administered from simple and 
less expensive analgesics to complex chemotherapeutic 
agents in the management of wound healing[2]. Appropriate 
method for healing of wounds is essential for the restoration 
of damaged anatomical continuity of tissue and disturbed 
functional status of the skin[3].
  Crotalaria verrucosa (C. verrucosa) belongs to family of 
fabacea, well known as blue rattlesnake. It is an erect shrub 
which grows to 80-100 cm high with angular branches. It has 
oviate to triangular leaves. The juice of its leaves is used 
in scabies and impetigo, and is considered efficacious in 
diminishing salivation. In Nigeria it is used for various skin 
infection, colic and flatulence. It is widely spread in tropics 
and is found in waste places of native India. However to 
the best of our knowledge a systematic study on wound 
healing activity of C. verrucosa has not been undertaken to 
evaluate the wound healing property of aqueous extract of 
C. verrucosa on various animal models in Wistar rats[4]. 
2. Materials and methods
2.1. Animal care and handling
  This was done as per the guidelines set by the Indian 
Objective: To evaluate the wound healing effect of aqueous extract of Crotalaria verrucosa (C. 
verrucosa) in rats. Methods: Three wound models including incision, excision and dead space 
wounds were used in this study. The parameters studied were breaking strength in incision 
models, granulation tissue dry weight, breaking strength and hydroxyproline content in dead 
space wounds, percentage of wound contraction and period of epithelialization in excision 
wound model. Results: Two doses of the extract with and without dexamethasone showed 
significant increases in mean hydroxyproline, total protein content and dry weight of granulation 
tissue but it was higher with dose 800 mg/kg comparing with the control. The dexamethasone 
treated group showed a significant (P<0.001) reduction in the wound breaking strength when 
compared to control group in incision type of wound model. Coadministration of C. verrucosa 
with dexamethasone significantly (P<0.001) increased the breaking strength compared to the 
dexamethasone treated only group. In excision wound model, the percentage of the wound 
contraction was significantly (P<0.01) increased by two doses of test extract on all the days except 
the lower dose which exhibited only on 12th, 16th days of drug treatment and it also reversed 
the dexamethasone suppressed wound contraction. It significantly (P<0.001) reduced the time 
required for epithelialization and reversed the epithelialization delaying effect of dexamethasone 
(P<0.001). Conclusions: C. verrucosa was found to possess significant wound healing property. 
This was evident by decrease in the period of epithelialization, increase in the rate of wound 
contraction, skin breaking strength, and granulation tissue dry weight content. Hence C. 
verrucosa could be a good wound healing agent. 
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National Science Academy, New Delhi, India. A total of 
108 healthy Wistar rats (150-200 g), aged twelve weeks of 
either sex, bred locally in the animal house of Kasturba 
Medical College, Manipal were selected for the study. They 
were housed under controlled conditions of temperature of 
(23依2) 曟, humidity of 50% and 10-14 h of light and dark 
cycles respectively. The animals were housed individually 
in polypropylene cages containing sterile paddy husk 
(procured locally) as bedding throughout the experiment and 
had free access to sterile food and water ad libitum. Animals 
were kept under fasting for overnight and weighed before 
the experiment. The study was undertaken after obtaining 
the approval of Institutional Animal Ethical Committee 
(IAEC approval letter No.IAEC/KMC/ 13/2009-2010 dated 14 th 
February 2009).
2.2. Collection and preparation of aqueous extract of C. 
verrucosa
  Dried leaves of C. verrucosa were crushed and soaked 
in water overnight which was later subjected to boiling 
for 6 hours. The resultant extract is then drained and 
concentrated on water bath and desiccators sequentially 
to yield 5% of concentrated extract. C. verrucosa plants 
were procured locally in January and authenticated by the 
professor of Botany, Mahatma Gandhi Memorial College, 
Udupi.
2.3. Acute toxicity studies
  Healthy Wistar rats of either sex were chosen and  divided 
into six groups (n=6). They were starved overnight. They 
were orally fed with graded doses of aqueous extract of C. 
verrucosa. Following the administration, the animals were 
closely observed during first 24 hours. The doses up to 3 g/kg 
were well tolerated without producing any signs of toxicity 
and mortality thus maximum tolerated dose was found.  In 
this study two doses of 400 mg and 800 mg were taken as 
lower and higher dose respectively. 
2.4. Study design
  The animals were randomly allocated into six groups with 
six animals each for the three experimental animal wound 
models. Group 1 received 2 mL of pure water by oral through 
intragastric tube. Group 2 and 3 received 400 mg/kg and 
800 mg/kg of C. verrucosa extract by oral route respectively. 
The dose selection was based on the acute toxicity studies. 
Group 4 received dexamethasone, (0.17 mg/kg, IM) ( DEXA 
group). Group 5 and 6 received DEXA (0.17 mg/kg, IM) + 
plants extract 400 mg/kg and DEXA (0.17 mg/kg, IM) + plants 
extract 800 mg/kg respectively.
  Dosing schedule - C. verrucosa extract and dexamethasone 
were administered orally and intramuscularly respectively 
once daily from day 0 to day 9 in the incision and dead 
space wound models and from day 0 to the day of complete 
wound healing or the 21st postoperative day, whichever 
occurred earlier in the excision wound model. In group 5 
and 6, C. verrucosa extract was given after the injection of 
dexamethasone.
2.5. Experimental wound models
  All wounding procedures were carried out under ketamine 
anaesthesia (10 mg/kg, im).
  Incision wound: Two paravertebral incisions of 6 cm length 
were made through the skin and muscles at a distance of 
about 1.5 cm from the midline on either side of the vertebral 
column. After the incision was made the parted skin is 
kept together and stitched at 0.5 cm intervals interrupted 
sutures using surgical thread and a curved needle. All the 
groups were treated in the same manner as per protocol. The 
sutures were removed on day 9 and the breaking strength 
of the wound was measured on day 10 by continuous and 
constant water flow technique[5]. 
  Dead space wound: Physical changes in the granuloma 
tissue were studied in this model. The dead space was 
inflicted on either side in the lumbar region through a small 
nick in the skin. Sterilized glass cylinder measuring (2.5伊
0.5) cm was introduced into the pouch[6]. The wounds were 
sutured and mopped with alcoholic swabs. Animals were 
placed in individual cages after recovery from anesthesia. 
The day of the wound creation was considered as day zero. 
On 10th post wounding day, the granulation tissue formed on 
the implanted tube is carefully dissected under anesthesia. 
Granuloma tissue from one tube was used for the estimation 
of hydroxyproline[7] and protein[8]. Granuloma from the 
other tube was cut into pieces measuring 15 mm in length 
and 5 mm in breadth and used for determination of wound 
tensile strength. As part of granulation tissue was sent for 
estimation of SOD catalase and reduled glutathione GSH 
levels.
  Excision wound: The excision wound was created on 
rats as described by Morton and Malon[9] by cutting away 
a 4.9 cm2 full thickness of skin from a predetermined 
area on the back of selected rat[10,11]. The excised wound 
was left open. Wound healing potential was determined 
by wound contraction and wound closure time (Period 
of epithelization). Wound area was measured by tracing 
the wound margin using 1 mm2 graph paper on the day 
of wounding and subsequently on alternative days until 
healing was complete. The healed area was calculated by 
subtracting wound area from the original wound area. The 
percentage of wound contraction was calculated using the 
formula:
  Percentage of wound contraction = (Healed area / Total 
wound area) 伊 100
 Number of days required for falling of eschar without any 
residual raw gives the period of epithelialization[12]. 
2.6. Statistical analysis
  Values are expressed in mean依SEM. Results were analysed 
by one way analysis of variance (ANOVA) followed by 
Scheffe’s test using SPSS computer package version 16. A 
P-value <0.05 was considered significant.  
3. Results
3.1. Incision wound model
  The mean breaking strength in the control group was (278.95
依2.40) g. The two doses of aqueous extract of C. verrucosa 
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showed significant increase in mean breaking strength when 
compared to control (P<0.001) (Table 1). In the dexamethasone 
treated group the mean breaking strength was (151.16依0.87) 
g which was significantly (P<0.001) decreased compared to 
control group. Coadministration of dexamethasone with C. 
verrucosa 400 and 800 mg has significantly (P<.001) increased 
the breaking strength to (359.20依2.59) g and (388.35依2.70) g 
respectively (Table 1).
3.2. Dead space model
  The mean breaking strength of granulation tissue in the 
control group was (218.94依1.02) g. A marked increase in 
breaking strength of the granulation tissue was observed 
in the two C. verrucosa groups compared to control (P<0.05) 
but more with higher dose 800 mg/kg (Table 2). The breaking 
strength in dexamethasone treated group was decreased 
significantly to (199.87依0.91) g compared to the control group 
(Table 2).
  The mean hydroxyproline, total protein content and dry 
weight of granulation tissue in control group were (13.47依0.17) 
mg/g, (79.56依0.35) mg/L and (40.88依0.52) mg respectively. 
The two doses of  the extract showed significant increase 
in mean hydroxyproline, total protein content and dry 
weight of granulation tissue but higher with dose  800 mg/
kg compared to control (Table 2). In dexamethasone treated 
group mean hydroxyproline, total protein content and dry 
weight of granulation tissue were (10.54依0.30) mg, (48.87依0.29) 
mg/L and (37.07依0.95) mg which were significantly (P<0.001) 
less compared to control group.  However coadministration 
of dexamethasone with C. verrucosa 400 and 800 mg has 
significantly (P<0.001) increased the mean hydroxyproline 
content to (24.43依0.21) g and (30.44依0.39) g respectively 
compared to only dexamethasone treated group (Table 2). 
Similar results noted when mean dry weight of granulation 
tissue and total protein estimations were done (Table 2). 
The catalase activity and glutathione synthase levels were 
significantly increased in the test group of 400 mg/kg and 
800 mg/kg compared to control (Table 3).
3.3. Excision wound
  The percentage of wound contraction was 27.78依0.56, 
48.56依0.56, 59.16依0.24 and 72.64依2.08 as measured on 4th, 
8th, 12th and 16th day respectively in the control group. The 
wound contraction was not altered in the 400 mg/kg dose 
group of C. verrucosa on 4th, 8th days of drug treatment but 
significantly increased on 12th and 16th day as compared to 
the control group (P<0.001). However a significant increase 
in wound contraction was seen in the higher drug treated 
group of 800 mg/kg compared to control on all 4th, 8th, 
12th and 16th days (Table 4).  Apart from this, we have also 
noted a positive trend of increasing wound contraction rate 
in C. verrucosa and negative trend of decreasing wound 
contraction rate in dexamethasone treated group and they 
were statistically significant on all the days compared 
to the control. Similar observation was also made in the 
dexamethasone & C. verrucosa treated group when compared 
to the dexamethasone treated group. The two doses of plant 
extract  400 mg/kg and 800 mg/kg exhibited statistically 
significant wound contraction rate where it increased from 
24.72依0.29 to 15.76依0.11 and 31.54依0.28 to 12.29依0.17 as 
compared to dexamethasone treated group from 4th to  16th 
day respectively (P<0.001) (Table 2).
  The mean period of epithelialization in the control group 
was (16.61依0.13) and  it was significantly reduced to (13.43 
依0.11) and (10.98依0.03) in  the lower and higher dose 
group respectively(P<0.001). Similarly in dexamethasone 
treated only group it was (18.18依0.10) days which was 
significantly (P<0.001) reduced to (15.76依0.11) and (12.29依
0.17) days with both (dexamethasone + 400 mg/kg plant extract 
and dexamethasone+800 mg/kg plant extract) treated group 
respectively (Table 4).
Table 1 
Effect of the aqueous extract of C. verrucosa on the incision wound model (n=6, Mean依SEM).
Group      Drugs         Dose and route Breaking strength (g)
Group 1      Control         2 mL of distilled water 278.95依2.38
Group 2      C. verrucosa         400 mg/kg, oral 322.16依1.85a
Group 3      C. verrucosa         800 mg/kg, oral 361.32依1.02a
Group 4      Dexamethasone         0.17 mg/kg, im 151.16依0.87a
Group 5      Dexa. +C. verrucosa         0.17 mg/kg,  im + 400 mg/kg, oral    359.20依2.60a , b
Group 6      Dexa.+C.verrucosa         0.17 mg/kg, im + 800 mg/kg, oral    388.35依2.71a , b
 Dexa- Dexamethasone;  aP<0.001 vs control, bP<0.001 vs Dexa,  One-way ANOVA. 
Table 2 
Effect of the aqueous extract of C. verrucosa on breaking strength, dry weight of granulation tissue, total protein and hydroxyproline in dead space 
model(n=6, Mean依SEM).
Group Drugs Dose and route
Breaking strength of 
granulationtissue (g)
Dry weight of






Group 1 Control 2 mL of distilled   water 218.94依1.02c 40.88依0.52c 79.56依0.35 13.47依0.17
Group 2 C. verrucosa 400 mg/kg, oral 254.79依3.52c 50.15依0.15c 82.24依0.68b 31.93依0.43c
Group 3 C. verrucosa 800 mg/kg, oral 284.19依1.73c 68.26依0.55a 101.56依0.96d 38.93依0.29c
Group 4 Dexamethasone 0.17 mg/kg, im 199.87依 0.91c 37.07依0.95a 48.87依0.29a 10.54依0.30c
Group 5 Dexa +C. verrucosa 0.17 mg/kg, im+400 mg/kg, oral 351.06依1.51c ,d 46.07依0.82a , d 50.71依0.24c 24.43依0.21d
Group 6 Dexa+C.verrucosa 0.17 mg/kg, im+800 mg/kg, oral 388.35依 2.70c , d 53.75依1.02c ,d 73.65依0.54d 30.44依0.39d
aP<0.05 vs control, bP<0.05 vs Dexa, cP<0.001  vs control , dP<0.001 vs Dexa. 
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4. Discussion
  Wound healing is an orderly progression of events 
that establish the integrity of the tissues. Many studies 
have shown that plant products are preferred in wound 
healing since they are devoid of side effects and are more 
effective[13]. Wound healing process begins with the 
restoration of a damaged tissue as closely as possible to 
its natural state and wound contraction is the course of 
shrinkage in wounded area. The healing primarily depends 
on the repairing ability of the tissue in addition to type and 
degree of damage and general health status of the tissue.
  Granulation, collagen maturation and scar formation 
are some of the many phases of wound healing which run 
concurrently, but independent of each other. Up to date 
there is no reference standard exists and the use of single 
model is inadequate to conclude which can represent 
distinctively the various phases of wound healing. Hence 
three different models have been chosen in our study to 
assess the effect of C. verrucosa on wound healing.
  The granulation tissue of the wound is primarily composed 
of edema, fibroblast, collagen and new blood vessels. The 
mesenchymal cells of the wound area adjust themselves into 
fibroblast then begin migrating into the wound gap together 
with the fibrin strands. The collagen is the main constituent 
of extra cellular tissue, which is responsible for support and 
strength. Free hydroxyproline and its peptides are released 
with collapse of collagen. Thus, measurement of the 
hydroxyproline could be used as an indicator for collagen 
turnover. Furthermore, increase in dry tissue also indicates 
the presence of elevated protein content.
  The wound breaking strength is determined by the rate of 
collagen synthesis and maturation process, wherein there is 
covalent binding of collagen fibrils through inter and intra 
molecular cross linking. In our study dead space model, 
there is not only marked increase in breaking strength 
of the granulation tissue but also significant increase in 
hydroxyproline content, total proteins and dry weight of 
granulation tissue was observed in the two doses of C. 
verrucosa compared to control. By this we can presume that 
the C. verrucosa might have increased the collagen content 
and probably altered the maturation process, by affecting the 
cross linking of collagen or improving the quality of collagen 
fibrils[14].
  Wound contraction is the process of mobilizing healthy 
skin surrounding the wound to cover the denuded area and 
involves complex and superbly orchesterated interactions 
of cells, extracellular matrix and cytokines. This centripetal 
movement of wound margin is believed to be due to the 
activity of myofibroblast[15]. Since C. verrucosa enhanced 
wound contraction, it would have either enhanced contractile 
property of myofibroblasts or increased the number of 
myofibroblasts recruited into the wound area. Granulation, 
collagen maturation and scar formation are some of the 
many phases of wound healing which run concurrently, 
but independent of each other[16]. A significant increase in 
wound contraction was seen in both doses of C. verrucosa 
compared to control. Hence it appears that C. verrucosa has 
prohealing effect as evidenced by the above findings. 
  In excision wound model C. verrucosa and C. verrucosa 
with dexamethasone hastened the period of epithelialization 
significantly during initial and later stages of wound 
contraction. It appears that C. verrucosa has prohealing 
effect as evidenced by the above findings and was able 
to promote epithelialization either by facilitating the 
proliferation of epithelial cells or by increasing the viability 
Table 3 
Antioxidant activity of the aqueous extract of C. verrucosa in dead space wound model(n=6, Mean依SEM, units/mg/min).
                   Groups Catalase activity GSH
                   Control 1.49依0.11  7.62依0.37
C. verrucosa 400 mg/ kg 2.14依0.15  6.23依0.29a
C. verrucosa 800 mg/ kg    3.35依0.23a  4.22依0.21a
aP<0.05 compared to control,  One-way ANOVA, SEM =Standard error of mean, GSH=glutathione.
Table 4   
Effect of the aqueous extract of C. verrucosa in excision wound model(n=6, Mean依SEM).
Group Dose and route
%  of wound contraction
 4th day 8th day  12th day 16th day  POE
Group1 Control 2 mL of distilled water 27.78依0.56 48.56依0.56 59.16依0.24 72.64依2.08  16.61依0.13
Group2 C. verrucosa 400 mg/kg, oral 28.13依0.72 48.56依0.56 69.04依0.27c 81.67依0.35c 13.43依0.11c
Group3 C. verrucosa 800 mg/kg, oral 33.08依1.03c 57.78依0.72c 81.38依0.49c 94.13依0.48c 10.98依0.03c
Group4 Dexa 0.17 mg/kg, im 22.16依0.60c 40.69依0.95c 50.31依0.29c 64.22依0.39c 18.18依0.10c
Group5 Dexa+ C. verrucosa 0.17 mg/kg, im+400 mg/kg, oral 24.72依0.29 44.03依1.21a 63.62依0.37cd 78.25依0.46ad 15.76依0.11ad
Group6 Dexa+C.verrucosa 0.17 mg/kg, im+800 mg/kg, oral 31.54依0.28ad 51.87依4.96d 72.51依0.76cd 83.12依0.65cd 12.29依0.17cd
Dexa- Dexamethasone, aP<0.05 vs control, cP<0.001  vs control , dP<0.001 vs Dexa;  POE- Period of epithelialization.
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of epithelial cells. It is difficult to draw any conclusion from 
the study regarding the dexamethasone & C. verrucosa effect 
in dexamethasone suppressed wound model.
  Oxidative stress is associated with many acute and 
chronic inflammatory conditions such as wound healing[17]. 
C. verrucosa has shown to possess anti-oxidant property. 
Flavonoids responsible for free radical scavenging activity 
were believed to be one of the important components in 
wound healing, however confirmation needs to be done by 
further phytochemical analysis. This could be the probable 
reason for pro-healing effect of C. verrucosa. Due to the 
various properties as discussed above C. verrucosa could 
be used to treat open wounds. However confirmation of this 
conclusion requires clinical evaluation.
  In conclusion, the present study demonstrated that the 
aqueous parts of C. verrucosa promote wound healing 
activity in animal as a preclinical study. The aqueous 
extract showed remarkable wound healing activity and it 
may be suggested for treating various types of wounds in 
animal and human beings. Further studies with purified 
constituents compared to the crude extracts might be needed 
to comprehend the complete mechanism of wound healing 
activity of C. verrucosa.
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